Neurological disorders including, brain tumors, stroke, MS Neurological disorders
Conditions
Interventions
A neuropsychological rehabilitation treatment (T-ScEmo: treatment of social cognition and emotion) involving training of social information processing and teaching strategies for social cognition and
Control condition: waiting list, to control for test-retest effects.
Sponsors
Universitair Medisch Centrum Groningen
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients should have a neurological disorder (see above); Age between 18 and 75; As prospects may be different for individual patients, patients should be in the chronic stage (> 6 months post acute injuries) or their medical condition should be relatively stable (for those with a slow progressive condition), to be judged by the treating medical or psychological specialist, in order to be able to profit from treatment for a reasonable time period. Also, the presence of a close other is an inclusion criterion
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Serious neurodegenerative or psychiatric conditions (including addiction) interfering with treatment - Incapacity to act, to be judged by the neuropsychologist and/or neurologist - Serious cognitive problems (aphasia, neglect, amnesia, dementia) and/or serious behavioral problems (aggression, apathy) interfering with treatment, to be judged by neuropsychologist. - Serious (other) medical conditions or physical inability hindering patients to come to the hospital/rehabilitation center, - Not being available of a close other (life partner, family member, close friend) who can fill out the proxy questionnaires - Not willing to give permission to send important/unexpected findings to the general practitioner - In addition: unexpected progression of disease during the study can be a reason to exclude the patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter is the difference between T2 (long-term follow-up) and T0 of the score on the Dutch version of the Dysexecutive Questionnaire- Social scales proxy version (DEX-Socproxy; Spikman et al., 2013; Westerhof-Evers, 2017). This is a measure for informant rated social competent behavior. The difference between T2 and T0 should be significantly larger than the difference in the control group to control for test-retest effects. T2 is chosen because we deem it relevant to establish that treatment effects last over time, that is, are still present at follow-up measurement. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints will be improvements on tests for social cognition, questionnaires for social abilities, social participation, quality of life (QoL), mood, relationship quality, goal attainment scaling (GAS), between T0 and T1, and T0 and T2 respectively. | — |
Countries
Netherlands
Contacts
Public ContactA Heegers
Universitair Medisch Centrum Groningen
Outcome results
None listed